Colorectal Lymphoma in the Setting of HIV: Case Report and Review of the Literature

AIDS Patient Care and STDs

Volumn 23, Issue 4, 2009, Pages 227-230

  Dinh, Minh H ^a   Matkowskyj, Kristina A ^a   Stosor, Valentina ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; EFAVIRENZ; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; RITUXIMAB; VINCRISTINE;

ADULT; ARTICLE; BLOOD SMEAR; BURKITT LYMPHOMA; CASE REPORT; COLORECTAL TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; DRUG MEGADOSE; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOPHENOTYPING; INTRACTABLE PAIN; MALE; RECTUM BIOPSY; RECTUM DISEASE; RECTUM PAIN; SIGMOIDOSCOPY;

BURKITT LYMPHOMA; COLORECTAL NEOPLASMS; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; RECTUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 64849085425     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2008.0185     Document Type: Article

References (18)

1. Blinder VS, Chadburn A, Furman RR, Mathew S, Leonard JP. Improving outcomes for patients with Burkitt lymphoma and HIV. AIDS Patient Care STDs 2008;22:175-187.
2. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008;148:728-736.
3. Carbone A, Gloghini A. AIDS-related lymphomas: From pathogenesis to pathology. Br J Haematol 2005;130: 662-670.
4. Spano JP, Costagliola D, Katlama C, Mounier N, Oksenhendler E, Khayat D. AIDS-related malignancies: State of the Art and Therapeutic Challenges. J Clin Oncol 2008;26:4834- 4842.
5. Ioachim H, Antonescu C, Giancotti F, Dorsett B, Weinstein M. EBV-associated anorectal lymphomas in patients with acquired immune deficiency syndrome. Am J Surg Pathol 1997;21:997-1006.
6. Cote TR, Biggar RJ, Rosenberg PS, et al. Non-Hodgkin's lymphoma among people with AIDS: Incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer 1997;73:645-650.
7. Wang ES, Straus DJ, Teruya-Feldstein J, et al. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer 2003;98: 1196-205.
8. Magrath I, Adde M, Shad A, et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 1996;14:925-934.
9. Gabarre J, Raphael M, Lepage E, et al. Human immunodeficiency virus-related lymphoma: Relation between clinical features and histologic subtypes. Am J Med 2001;111:704- 711.
10. Wong N, Eu K. Primary colorectal lymphomas. Colorectal Dis 2006;8:586-591.
11. Li B, Shi Y, He X, et al. Primary non-Hodgkin lymphomas in the small and large intestine: Clinicopathological characteristics and management of 40 patients. Int J Hematol 2008;87:375-381.
12. Doolabh N, Anthony T, Simmang C, Bieligk S, Lee E, Huber P. Primary colonic lymphoma. J Surg Oncol 2000;74: 257-262.
13. Burkes RL, Meyer PR, Gill PS, Parker JW, Rasheed S, Levine AM. Rectal lymphoma in homosexual men. Arch Intern Med 1986;146:913-915.
14. Parente F, Rizzardini G, Cernuschi M, Antinori S, Fasan M, Porro GB. Non-Hodgkin's lymphoma and AIDS: Frequency of gastrointestinal involvement in a large Italian series. Scand J Gastroenterol 1993;28:315-318.
15. Estes J, Baker JV, Brenchley JM, et al. Collagen deposition limits immune reconstitution in the gut. J Infect Dis 2008;198:1-9.
16. Just PA, Fieschi C, Baillet G, Galicier L, Oksenhendler E, Moretti JL. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in AIDS-related Burkitt lymphoma. AIDS Patient Care STDs 2008;22:695-700.
17. Oriol A, Ribera JM, Bergua J, et al. High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: Comparison of results in human immunodeficiency virus-infected and noninfected patients. Cancer 2008;113: 117-125.
18. Kaplan LD, Lee JY, Ambinder RF, et al. Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood 2005;106:1538-1543.